Prot: 42756493BLC1003: Phase 1 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants with Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer and Selected FGFR Mutations or Fusions

Project: Research project

Project Details

StatusActive
Effective start/end date10/25/22 → 12/31/27

Funding

  • Janssen Research & Development, LLC (Prot: 42756493BLC1003)